EcoSmart Pen Launching Soon First Smart Vape Pen with Customer/Patient Feedback System for the Cannabis Market. Patent filed November 28, 2017 (Est Date Available: June 30 - September 30, 2018)
The ECO Smart Pen(TM) Powered by MyDx is a next generation, rechargeable vaporizer pen equipped with Bluetooth technology that helps patients and consumers better manage and regulate their cannabis consumption habits and effects.
The ECO Smart Pen(TM) immediately activates the MyDx App via bluetooth with any compatible cartridge. The pen will then passively monitor your consumption habits, such as dosage and frequency of use. You’ll also be able to activley track which ailments the product relieved and/or feelings it generated and how many doses it took to generate those feelings and/or reliefs.
Parents can use the Child Lock Feature to protect their children from accidentally using their Pen.
Consumers can ensure no one else can access their pen and precious cartridges without their consent via the EcoSmartPen App.
Patients get to track their consumption habits (dosage, chemical profile and associated effects) to find the best product(s) working for them.
Doctors will be better equipped to manage their patient prescriptions by having access to more detailed information about what works and how much is needed to provide relief.
Brands will be able to private label (OEM) and purchase the smart pen hardware and associated software ecosytem using their brand name to provide a more sophisticated vape pen experiene for their customer-base.
Concentrate Manufacturers will be able to access relevant data via licensing arrangements with MyDx for their own product development initiatives.
Recent Deals/Partnerships of Interest: GANJA GOLD VIDEO of MYDX PEN(MAY 17, 2018): Going LIVE in July 2018 https://twitter.com/GANJA_GOLD/status/997205343443865601 Watch towards the end if you don't want to wait... it is short though Humanity Products http://humanitymedicine.com On April 9, 2018, the Company verbally agreed to enter into a License and Services Agreement with Humanity Holdings Inc. and Humanity Products, Inc. (collectively “Humanity Holdings”). Humanity Holdings currently operates a manufacturing and distribution facility, licensed by the state of California, through which it engages in the sale and distribution of various cannabis related products. The Company granted Humanity Holdings a non-exclusive license to manufacture, sell, and distribute products within California using proprietary product formulations owned or licensed by the Company. The Company agreed to issue Humanity Holdings shares of Common Stock worth $25,000 on the 45th day following the effective date of the agreement. This is in exchange for Humanity Holdings not contracting with a competitor of the Company who provides formulation services, smart vape device hardware and related software applications to its network, product branding or access to reporting from its data set that ties a user’s experience to a chemical profile of the product they are consuming. Humanity Holdings will pay 20% of net sales to the Company as a support services fee and 30% of net sales to the Company as a royalty. Source: https://www.last10k.com/sec-filings/mydx (see April 2018 10k) Ganja Gold www.ganjagold.org On January 26, 2018 the company entered into a joint venture with Ganja Gold to form “NewCo”. With the formation of NewCo, the intent is for the Parties to manufacture and distribute a new premium line of physiological based Vape formulations under Ganja Gold Vape Brand (“GGV”). The GGV Brand will be powered by MYDX data and formulations utilizing the Eco Smart Pen Device under an exclusive license of MYDX Power Formulations. MyDx will have the option to acquire 50% of NewCo. Source: https://www.last10k.com/sec-filings/mydx (see April 2018 10k) Black Swan Source: https://www.prnewswire.com/news-releases/mydx-enters-into-an-80000-mydx360-saas-licensing-and-services-agreement-with-retailer-blackswan-300475524.html Phylos Biosciences phylosbioscience.com On November 3, 2017 the Company and Phylos Bioscience, Inc. (“Phylos”) entered into a License, Co-Marketing, and Data Sharing Agreement (the “Phylos Agreement”). Pursuant to the Phylos Agreement, the Company and Phylos each granted a non-exclusive license to the other party to access their data and use their trademarks and logo on marketing materials. Neither party paid cash or issued shares in connection with the Phylos Agreement. The license was the consideration given by each party. The term of the agreement is five (5) years. Source: https://seekingalpha.com/filing/3766219 Highsmen https://www.highsmen.com/ Source: https://www.prnewswire.com/news-releases/mydx-forms-exclusive-partnership-with-highsmen-genetics-to-offer-custom-cannabis-strains-tailored-for-desired-physiological-effects-300577228.html
Market Cap $13,870,222 05/25/2018
Authorized Shares 10,000,000,000
Outstanding Shares 3,797,058,506
Held at DTC 1,623,727,487